APG-1252 in Patients With SCLC or Advanced Solid Tumors

Clinical trial NCT03387332 · TERMINATED

Trial details

NCT number: NCT03387332
Sponsor: Ascentage Pharma Group Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer and Other Solid Tumors

Start date: 2017-12-01
Primary completion: 2020-11-09
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.